Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

Rotavirus Efficacy and Safety Trial (REST) enrolled nearly 70,000 infants, of whom more than 23,000 were from Finland. REST determined the efficacy of the pentavalent rotavirus vaccine (RV5) against rotavirus-related hospitalisations and emergency department (ED) visits in the first year after vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesikari, Timo, Karvonen, Aino, Ferrante, Shannon Allen, Ciarlet, Max
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943584/
https://www.ncbi.nlm.nih.gov/pubmed/20559656
http://dx.doi.org/10.1007/s00431-010-1242-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943584/
https://www.ncbi.nlm.nih.gov/pubmed/20559656
http://dx.doi.org/10.1007/s00431-010-1242-3

Ejemplares similares